Oxidative stress and pulmonary fibrosis | 2013/07/01 | English | 321 |
Diffusion tensor imaging of cerebral white matter integrity in cognitive aging | 2012/03/01 | English | 317 |
Voltage-dependent anion channel (VDAC) as mitochondrial governator—Thinking outside the box | 2006/02/01 | English | 317 |
Stroke injury, cognitive impairment and vascular dementia | 2016/05/01 | English | 313 |
The molecular targets of resveratrol | 2015/06/01 | English | 311 |
Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target | 2006/11/01 | English | 309 |
Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world | 2004/12/01 | English | 308 |
The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling | 2017/01/01 | English | 305 |
Imaging of colorectal adenocarcinoma using FT-IR microspectroscopy and cluster analysis | 2004/03/01 | English | 301 |
Axonal transport and neurodegenerative disease | 2006/11/01 | English | 300 |
Carotenoids as modulators of lipid membrane physical properties | 2005/05/01 | English | 296 |
Antioxidant therapies in traumatic brain and spinal cord injury | 2012/05/01 | English | 290 |
Tau phosphorylation: physiological and pathological consequences | 2005/01/01 | English | 287 |
Current advances in ischemic stroke research and therapies | 2020/04/01 | English | 287 |
Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction | 2015/11/01 | English | 286 |
Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair | 2013/07/01 | English | 285 |
Ergothioneine; antioxidant potential, physiological function and role in disease | 2012/05/01 | English | 285 |
Manganese superoxide dismutase, MnSOD and its mimics | 2012/05/01 | English | 283 |
Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity | 2012/05/01 | English | 280 |
Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2–Keap1 signaling | 2011/07/01 | English | 276 |
Targeting antioxidants to mitochondria: A new therapeutic direction | 2006/02/01 | English | 275 |
The cellular prion protein (PrPC): Its physiological function and role in disease | 2007/06/01 | English | 271 |
MicroRNAs and the cell cycle | 2011/05/01 | English | 269 |
Tau, tangles, and Alzheimer's disease | 2005/01/01 | English | 263 |
Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeutics | 2012/05/01 | English | 262 |
Mutations causing neurodegenerative tauopathies | 2005/01/01 | English | 260 |
Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain | 2014/09/01 | English | 256 |
Neuroprotective action of resveratrol | 2015/06/01 | English | 254 |
Biomarkers and diagnostics in heart failure | 2013/12/01 | English | 251 |
Cytokine mediated tissue fibrosis | 2013/07/01 | English | 249 |